Futuragene Share Discussion Threads

[n_w_b] 06/10/2009 08:10

Liked the sound of this one and acquired a few, in several instalments yesterday.

Liked the sound of "trade of the decade"; wasn't that GKP, or will this multibag more?

Billions of dollars of additional output a year, for a little minnow worth £25m, with EVO mentioning it could be worth £700m in a couple of years.

It's nice to get in prior to them spreading the word in the investment community.

[kooba] 05/10/2009 21:38

mentioned in ft market report again.

FuturaGene was in focus on Monday, rising 4.7 per cent to 50p after Evolution Securities said the plant cell modification specialist could be the "trade of the decade", write Neil Hume and Bryce Elder.

"Wide adoption of FuturaGene's technology could add billions of dollars to the annual output of the forestry and biofuel industries," said analyst Philip Sparks, adding that potential profits could dwarf the company's current market value of £25m.

FuturaGene claims its genetic technology can boost crop yields by 25 to 300 per cent, as well as increasing the stress tolerance of plants, allowing them to grow in hostile environments

[safman] 05/10/2009 12:18

volume picking up on this... interesting robson..

saffy..

[robson1974] 05/10/2009 11:55

NH
because Futuragene could be the "Trade of the Decade"
BE
Er - says who?
NH
Evolution Securities analyst Phil Sparks
NH
he has penned a big note on the stock
NH
and I don't think he is house broker
NH
he reckons FUG
NH
could be worth £700m in a couple of years' time
BE
Versus 24m quid today.
BE
These were 8p a year ago, and have already pushed up to 50p.
NH
yes
Futuragene (FGN:LSE): Last: 47.75, no change, High: 47.75, Low: 47.75, Volume: 0.00
BE
Five-bagger for some lucky punter.
BE
Anyway, do you have this bit of research to share?
NH
I do.
NH
Murph this is for you
NH
Relentless population growth is placing a severe strain on our agricultural
resources. By 2020 the world's forests and farms will have to provide
timber and food for 800m more people than they do today. The drive to
boost crop yields led to a twenty-fold increase in Monsanto's share price
in the last decade; we think similar trends will make FuturaGene a stellar
performer in the next
NH
Yield-enhancing technology for the forestry and biofuel sectors
FuturaGene's genetic technology can boost farm and forestry crop yields by
25-300%, depending on species. It can also accelerate growth, improve stress
tolerance and enhance productivity in paper and biofuel processing plants.
NH
Billion-dollar customers in billion-dollar markets
The Top 10 wood-producing countries exported $100bn of forestry products in
2005, so a 25% yield increase would create more than $25bn of value a year.
Unsurprisingly, several major forestry and agricultural players have expressed
interest in FuturaGene's technology.
NH
A hidden gem with huge potential
Although FuturaGene has made excellent progress with customers in recent
years, a legal dispute – now fully resolved – with the company's founders
prevented the current management from promoting the story to investors. We
now expect a more active approach to investor relations and positive newsflow
from the Suzano partnerships – and a significant boost to FuturaGene's profile.
Demographic trends suggest that the next decade will be extremely interesting
for FuturaGene and its shareholders. Wide adoption of FuturaGene's technology
could add billions of dollars to the annual output of the forestry and biofuel
industries. Even if FuturaGene captured only a tiny proportion of that value, its
profits would dwarf the company's current market cap of £25m. BUY.
BE
Oh. Right. It's one of those "captured only a tiny proportion" notes ...
BE
Target price?
NH
100p at the moment

[sportbilly1976] 05/10/2009 11:55

comment on this am's FT alphaville....

[safman] 09/9/2009 07:33

TIDMFGN

RNS Number : 7280Y
Futuragene PLC
09 September 2009

?

FUTURAGENE PLC


FuturaGene to develop enhanced poplar for the Chinese biofuel and biopower
markets


9 September 2009. Rehovoth, Israel. FuturaGene PLC, ("FuturaGene" or "the
Group", AIM: FGN), a leader in plant genetic research and development for
global forestry, biofuel and agricultural markets, has entered into an Agreement
with the Chinese Academy of Forestry ("CAF") to develop new enhanced poplar with
increased yield, processability and abiotic stress characteristics for the
Chinese domestic market.


Futuragene will provide proprietary genes and technical assistance to Professor
Liwang Qi, Chief Expert on Silva Genetics at CAF in Beijing. The programme aims
at improving yield, drought and salt tolerance of short-rotation poplar for the
biofuel and biomass markets.


Woodchip from poplar produced in sustainable, renewable plantations provides a
carbon-neutral fuel source for co-firing coal-burning power stations,
significantly reducing environmental damage. Poplar is also being developed for
the production of second generation cellulose-to-ethanol biofuel. The rapid
growth rate of poplar makes this species an ideal candidate for renewable
biomass for energy production reducing the need to use food crops as a raw
material for liquid fuel production.


In addition to development work, field trials and regulatory authorisation will
be carried out by CAF. Both parties will have joint rights for commercialisation
of varieties produced under the Agreement in the Chinese domestic market.


This Agreement is the second collaboration between FuturaGene and CAF. The first
agreement was signed in 2007 and aimed at improving yield, processability and
disease resistance of eucalyptus trees.


Dr. Stanley Hirsch, Group Chief Executive of FuturaGene commented:


"We are delighted to be extending our relationship with CAF, following the
productive start to our initial eucalyptus-focused collaboration agreement. This
agreement on poplar is strategically important to our global initiatives in the
development of this crop for biopower and second generation biofuel production.


"Poplar is widely used in China as a structural wood, for fibre and to reverse
desertification. There is increasing interest in utilising poplar as a carbon
neutral biomass for renewable energy. As China is currently one of the largest
users of coal, the introduction of poplar as an energy source for
combustion, potentially has a substantial global environmental benefit.


"Professor Qi has been a significant contributor to poplar research in China and
we are sure that this new partnership will bring mutual benefit to both
parties."


Professor Liwang Qi added


"We are confident that Futuragene's technologies can make a significant
contribution to the improvement of poplar varieties in China and are pleased to
have this opportunity to work closely with them."


saffy..

[leadersoffice] 25/8/2009 08:32

lovely read we havent seen anything like that since 2004 guardian share tips.

[dgo] 23/8/2009 14:57

This should make it move.

[leadersoffice] 10/8/2009 15:05

By the activity today looks like we may have some news shortly

dyor

[leadersoffice] 10/8/2009 08:08

Some buying this morning... small that it be

[kooba] 31/7/2009 10:54

little bit of interest building..some retail buying.

[kooba] 26/7/2009 18:11

not new but encouraging press release from july 13th .
hoping for licensing deal with perhaps accompanying share subscription at a decent premium from monsanto but its all gone a bit quiet following the press coverage in june.

[leadersoffice] 18/6/2009 15:48

Come on im looking for an annoucement!

[safman] 11/6/2009 16:04

hopefully soon, again, FGN is in a sector that i certainly do like, also with PIM.

best of..

saffy..

[leadersoffice] 11/6/2009 11:27

Wonder when this might be announced?

[safman] 08/6/2009 12:04

There is plenty of stuff on the horizon with FGN... a few days ago in the ft..



Futuragene was in demand yesterday. Its shares took on 7.8 per cent to 62½p on rumours that the company, specialist in plant cell wall modification for the biofuel, forestry and agricultural markets, was in advanced dis-cussions with Monsanto on a possible licensing deal.

Futuragene has struck a deal with one of the world's biggest forestry companies, which has also taken a 9 per cent stake in the company.

saffy..

[safman] 05/6/2009 10:16

moving up strongly..

in the ft today..

"Futuragene rumoured to be in discussions with Monsanto on possibility of a licensing deal"

saffy..

[safman] 21/5/2009 07:54

TIDMFGN

RNS Number : 6131S
Futuragene PLC
21 May 2009

?
FUTURAGENE PLC ("FuturaGene" or the "Company")


FuturaGene's Wholly Owned Subsidiary, CBD Technologies, Ltd. ("CBD Tech") and
Targeted Growth, Inc. ("TGI") to begin Field Trials in Corn and Amend Licensing
Agreement


Rehovot, Israel
21 May 2008


FuturaGene, which develops environmentally friendly solutions that enhance crop
yields and improve the processability of plants for biofuels, biopower, forestry
and agriculture announces that Targeted Growth, Inc. is to initiate the first
field trials with corn, modified with technology from CBD Tech. The technology
is aimed at enhancing plant processability and digestibility as well as other
agronomic properties. The trials are aimed at screening for altered lines to
take forward in the development pathway.


CBD Tech has also amended its licensing agreement of 19 March 2008 (the
"Agreement") with TGI for the enhancement of corn and soybean. As TGI is to
focus its efforts on the enhancement of corn with the technology from CBD Tech,
it has decided not to initiate work on soybean and the amended Agreement will no
longer include this crop. As detailed above, TGI continues to progress with
corn and all terms, definitions, provisions and conditions of the Agreement
remain in full force and effect with respect to this latter crop.


For further information, please contact:




FuturaGene Plc
Mark Pritchard, Chairman
[phone]
Dr. Stanley Hirsch, Group CEO
[phone]


Evolution Securities
Neil Elliot
[phone]


Targeted Growth, Inc.
John Williams, Scoville PR
[phone]




About FuturaGene PLC


FGN is a leading agricultural biotechnology company focused on research,
development,
and commercialisation of technologies that play key roles in substantially
improving
agronomic traits of value in plants. In particular the Company is focused on the
development and commercialisation of genetically modified plants for improving
and
protecting yields, and enhancing processability and environmental sustainability
in the
forestry, biofuels, biopower and agricultural sectors. In addition to its
in-house discovery program, FuturaGene licenses intellectual property from
leading universities in its strategic fields of interest and is exploiting the
synergies of these technologies with the cell wall modification platform of its
wholly owned subsidiary, CBD Technologies, Inc. (CBD Tech) in forestry, biofuel,
biopower, food and feed crops.


CBD Tech has pioneered a modality for modifying plant cell walls, resulting in
enhanced growth and biomass, increased cellulose, improved fiber properties,
improved digestibility and processability, and increased yield properties and
has secured broad intellectual property covering plants with modified cell walls
showing such altered properties. More information is available at
www.futuragene.com.




About Targeted Growth Inc.
TGI uses agricultural bioscience to enable the long term success of renewable
fuels such as biodiesel and ethanol. This includes technology that improves the
traits of crops themselves (yield increases, drought resistance, fertilizer
requirements, etc.) and the ultimate performance of those crops once converted
into biofuels (efficiency of refining, fuel performance characteristics). In
addition, the company also develops, grows and markets biofuel specific crops
(such as camelina) that are optimised and continually improved for use
specifically as a feedstock for biofuels. The company has strategic partnerships
with leading researchers and agribusinesses around the world. Targeted Growth is
based in Seattle, Washington with labs in Seattle, Saskatchewan, Ottawa and New
Brunswick. More information is available at www.targetedgrowth.com.



This information is provided by RNS
The company news service from the London Stock Exchange
END

MSCILFEDEAIIFIA

saffy..

[leadersoffice] 12/5/2009 07:10

The highest they went to was back in 2004 just 6 or 7 months after the RTO
They reached £2.20. Scary that was 5 years ago. Where does the time go!

[safman] 11/5/2009 18:26

yeah, i think its one of those stocks whose potential could be massive imho. a bit of history off the top of my head , is that i think this went to around 1.70/1.80 .. not the 2.80..

if you can increase crop yield in todays world, then the potential may well be massive..

saffy...

[leadersoffice] 11/5/2009 18:20

I will be honest... there is life after death. I hadnt expected there to be a turn about with this share. I bought in @ 98p so have a some miles to go to recoup my losses. But it looks like we could be seein the days when this share touched £2.80 a few years ago.
dyor

[johnlll] 11/5/2009 17:20

Very positive news. Very happy indeed with my investment here.

[safman] 11/5/2009 11:22

RNS Number : 0180S
Futuragene PLC
11 May 2009









FUTURAGENE PLC ('FuturaGene' or the 'Company')




FuturaGene's Wholly Owned Subsidiary, CBD Technologies, Ltd. ('CBD

Tech') announces that it has entered into a collaborative agreement with
Oregon State University.




Rehovoth, Israel

11 May 2009




FuturaGene, which develops environmentally friendly solutions that enhance yields and improve the processability of plants for forestry, biofuels, biopower and agriculture, is pleased to announce that its wholly owned subsidiary, CBD Technologies Ltd., has embarked on a unique collaboration with Dr. Steven H. Strauss of Oregon State University (OSU) under which the company will provide Dr. Strauss's research group with a proprietary eucalyptus clone and a highly efficient eucalyptus transformation protocol developed by CBD Tech. The collaboration will facilitate rapid and efficient evaluation of genes for flowering control and other biosafety aspects of tree modification. Although eucalyptus is the most widely planted commercial plantation tree species for pulp and paper production in the world, this species is notoriously difficult to transform. Thus, the supply of a proprietary clone and transformation method from the company to a public research institute, under appropriate material usage and confidentiality provisions, represents a significant contribution to accelerating public research and development in this species. In addition CBD Tech intends to join the Tree Biosafety and Genomics Research Cooperative (TBGRC), an internationally recognised tree research consortium that has been working with forest industries on tree biotechnology for 15 years. It is directed by Dr. Steven H. Strauss, a Distinguished Professor of Forest Biotechnology at Oregon State University in the USA.



'We are excited to launch this collaboration with OSU and TBGRC' said Dr. Ziv Shani, Vice President Research & Development of CBD Tech. 'As a pioneer of plant cell wall modulation technology, CBD Tech has accumulated a vast knowledge base and experience in enhancing plant biomass and yield. We have implemented our technology in eucalyptus and poplar, as well as other crops, and we are currently conducting several field trials around the globe. Our collaboration with OSU is an expression of our commitment to ensure the deployment of ecologically sound and sustainable yield enhancing technologies in the forestry, biofuels, biopower and agriculture industries.
Dr. Strauss has been a leader in the development of environmentally responsible tree modification technologies for many years and we are proud to be associated with him. We look forward to providing technology to Dr. Strauss to accelerate the OSU and TBGRC programs, especially as they broaden their scope from poplar to eucalyptus.'




Dr. Steven Strauss, Director of TBGRC said: 'We are very interested to begin aggressive studies to improve biosafety and the productivity of eucalypts. With the eucalypt genome sequence nearly completed by the US Department of Energy, there are a lot of fundamental avenues for scientific and technological advancement that require highly efficient gene transfer methods. We are anxious to work closely with CBD Tech to adapt their advanced methods to our laboratory environment.'




FuturaGene Plc

Mark Pritchard, Chairman [phone]

Dr. Stanley Hirsch, Group CEO [phone]




Evolution Securities

Neil Elliot [phone]



About FuturaGene PLC




FGN is a leading agricultural biotechnology company focused on research, development, and commercialisation of technologies that play key roles in substantially improving agronomic traits of value in plants. In particular the Company is focused on the development and commercialisation of genetically modified plants for improving and protecting yields, and enhancing processability and environmental sustainability in the forestry, biofuels, biopower and agricultural sectors. In addition to its in-house discovery program, FuturaGene licenses intellectual property from leading universities in its strategic fields of interest and is exploiting the synergies of these technologies with the cell wall modification platform of its wholly owned subsidiary, CBD Technologies, Inc. (CBD Tech) in forestry, biofuel, biopower, food and feed crops.




CBD Tech has pioneered a modality for modifying plant cell walls, resulting in enhanced growth and biomass, increased cellulose, improved fibre properties, improved digestibility and processability, and increased yield properties and has secured broad intellectual property covering plants with modified cell walls showing such altered properties. More information is available at www.futuragene.com.




About TBGRC

The Tree Biosafety and Genomics Research Cooperative (TBGRC) was established in 1993. Its aim is to conduct research, technology transfer, and education to facilitate responsible uses of genetically engineered trees in plantations. The TBGRC seeks to test and develop select innovations, based on progress in molecular biology and agricultural biotechnology that will ultimately have commercial value to wood-growing, bioenergy, and horticultural industries. Research is focused on poplar and eucalypts as scientific models for genetic engineering and functional genomic studies. Experiments underway are aimed at discovery of genes with major value for control of fertility, flowering onset, crown form, wood quality, and stature. A key theme of TBGRC research is the identification and testing of genes that can promote both economic and environmental benefits. The Director, Dr. Steven H. Strauss, is a Fellow of the American Association for the Advancement of Science and a Distinguished Professor at Oregon State University. He was recognized as 'Forest Biotechnologist of the Year' in 2009 by the Institute of Forest Biotechnology Partners (www.forestbiotech.org). The award is '...given to the forest biotechnologist who best exemplifies responsible uses of forest biotechnology, and actively promotes science, dialogue, and stewardship through their work'.


This information is provided by RNS
The company news service from the London Stock Exchange

END


NRAGGGMKGMRGLZM

looking good..

saffy..